These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 7013721)

  • 1. Disopyramide and mexiletine: which is the agent of choice in the long term-oral treatment of lidocaine-responsive arrhythmias? Efficacy comparison in a randomized trial.
    Trimarco B; Volpe M; Ricciardelli B; Sacca' L; De Luca N; Rengo F; Condorelli M
    Arch Int Pharmacodyn Ther; 1980 Dec; 248(2):251-9. PubMed ID: 7013721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy of disopyramide and mexiletine per os in the chronic treatment of ventricular arrhythmias sensitive to lidocaine].
    Ricciardelli B; Volpe M; De Luca N; D'Ascia C; Bonaduce D; Trimarco B; Rengo F; Condorelli M
    Boll Soc Ital Cardiol; 1981; 26(2):139-44. PubMed ID: 7337769
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative study of the antiarrhythmic efficacy of mexiletine and disopyramide in patients with chronic ventricular arrhythmias.
    Breithardt G; Seipel L; Lersmacher J; Abendroth RR
    J Cardiovasc Pharmacol; 1982; 4(2):276-84. PubMed ID: 6175812
    [No Abstract]   [Full Text] [Related]  

  • 4. [The new antiarrhythmia drugs disopyramide and mexiletine].
    Härtel GU
    Duodecim; 1980; 96(5):420-9. PubMed ID: 7449686
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of the antiarrhythmic efficacy of mexiletine in patients with chronic ventricular arrhythmias.
    Van Durme JP
    Acta Cardiol Suppl; 1980; (25):121-5. PubMed ID: 6990664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mexiletine in the treatment of ventricular arrhythmias].
    Tanaka T; Kusumoto M; Miyazawa Y; Umemura J; Suwa J; Komatsu Y
    Kokyu To Junkan; 1986 Mar; 34(3):315-9. PubMed ID: 3704375
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative trial of mexiletine and lignocaine in the treatment of ventricular arrhythmias.
    Sathyamurthy I; Krishnaswami S; Padmakumar P; Mao R
    Indian Heart J; 1985; 37(6):361-5. PubMed ID: 3915491
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparative study of the anti-arrhythmic activity of mexiletine and lidocaine in ventricular hyperkinetic arrhythmias].
    Rolli A; Bonatti V; Finardi A; Favaro L; Botti G
    G Ital Cardiol; 1981; 11(4):468-76. PubMed ID: 6169578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the antiarrhythmic efficacy of disopyramide and mexiletine against stimulus-induced ventricular tachycardia.
    Breithardt G; Seipel L; Abendroth RR
    J Cardiovasc Pharmacol; 1981; 3(5):1026-37. PubMed ID: 6168848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mexiletine in clinical practice.
    Boyle DM
    Acta Cardiol Suppl; 1980; (25):137-45. PubMed ID: 6990665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of ventricular arrhythmias with mexiletine].
    Trenckmann H; Neugebauer A; Krosse B
    Z Gesamte Inn Med; 1982 May; 37(9):259-62. PubMed ID: 7048773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mexiletine vs. lignocaine in the management of ventricular arrhythmias after open-heart surgery.
    Bury RW; Hale G; Higginbotham M; Mashford ML; Zuidland P
    Med J Aust; 1982 Mar; 1(6):265-7. PubMed ID: 7045605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerability and antiarrhythmic efficacy of disopyramide compared to lignocaine in selected patients with suspected acute myocardial infarction.
    Rønnevik PK; Gundersen T; Abrahamsen AM
    Eur Heart J; 1987 Jan; 8(1):19-24. PubMed ID: 2880718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the effects of lignocaine and mexiletine on experimental ventricular arrhythmias.
    Allen JD; Kelly JG; James RG; Shanks RG; Zaidi SA
    Postgrad Med J; 1977; 53 Suppl 1():35-47. PubMed ID: 876952
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of the antiarrhythmic activity of mexiletine and lorcainide on ventricular arrhythmias.
    Meinertz T; Kasper W; Stengel E; Waldecker B; Löllgen H; Jähnchen E; Bechtold H; Just J
    Z Kardiol; 1982 Jan; 71(1):35-8. PubMed ID: 7039160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-arrhythmic efficacy of the amiodarone-mexiletine combination in the treatment of resistant complex ventricular arrhythmias].
    Purcaro A; Massacci C; Curzi G; Pigini G; Costantini C; Bilancini A; Blandini A
    G Ital Cardiol; 1986 May; 16(5):417-26. PubMed ID: 3732727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral tocainide versus disopyramide: a double-blind, randomized, crossover study of outpatients with stable ventricular premature beats.
    McLaran CJ; Hossack KF; Neilson GH; Siskind V
    J Cardiovasc Pharmacol; 1984; 6(4):657-62. PubMed ID: 6206321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the efficacy of propafenone versus disopyramide for complex premature ventricular contractions. Evaluation with long-term monitoring.
    Naccarella F; Palmieri M; del Corso P; Lombardi G; Bracchetti D
    Arzneimittelforschung; 1982; 32(5):547-50. PubMed ID: 7201833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mexiletine in the treatment of ventricular arrhythmias (author's transl)].
    Schlemmer M; Wimmer M
    Padiatr Padol; 1982; 17(2):383-9. PubMed ID: 6179031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of disopyramide and mexiletine used alone and in combination for ventricular arrhythmias in patients with and without overt heart disease.
    Tanabe T; Takahashi K; Yoshioka K; Goto Y
    Int J Cardiol; 1991 Sep; 32(3):303-12. PubMed ID: 1724233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.